Inflammation VLA October 4, 2011 Inflammation nInflammation is the response of living tissue to damage. The acute inflammatory response has 3 main functions. ØThe affected area is occupied by a transient material called the acute inflammatory exudate. The exudate carries proteins, fluid and cells from local blood vessels into the damaged area to mediate local defenses. ØIf an infective causitive agent (e.g. bacteria) is present in the damaged area, it can be destroyed and eliminated by components of the exudate. ØThe damaged tissue can be broken down and partialy liquefied, and the debris removed from the site of damage. Etiology nThe cause of acute inflammation may be due to physical damage, chemical substances, micro-organisms or other agents. nThe inflammatory response consists of changes in blood flow, increased permeability of blood vessels and escape of cells from the blood into the tissues. The changes are essentially the same whatever the cause and wherever the site. nAcute inflammation is short-lasting, lasting only a few days. Inflammation nIn all these situations, the inflammatory stimulus will be met by a series of changes in the human body; it will induce production of certain cytokines and hormones which in turn will regulate haematopoiesis, protein synthesis and metabolism. nMost inflammatory stimuli are controlled by a normal immune system. The human immune system is divided into two parts which constantly and closely collaborate - the innate and the adaptive immune system. Inflammation nThe innate system reacts promptly without specificity and memory. Phagocytic cells are important contributors in innate reactivity together with enzymes, complement activation and acute phase proteins. nWhen phagocytic cells are activated, the synthesis of different cytokines is triggered. These cytokines are not only important in regulation of the innate reaction, but also for induction of the adaptive immune system. There, specificity and memory are the two main characteristics. Inflammation nIn order to induce a strong adaptive immune response, some lymphocytes must have been educated to recognise the specific antigen on the antigen-presenting cell (APC) in context of self major histocompatibility molecules. The initial recognition will mediate a cellular immune reaction, production of antigen-specific antibodies or a combination of both. Some of the cells which have been educated to recognise a specific antigen will survive for a long time with the memory of the specific antigen intact, rendering the host "immune" to the antigen. Differences between innate (non-specific) and specific (adaptive) immunologic reaction of organism nNon-specific Immunity n nResponse is antigen-independent n nThere is immediate maximal response n nNot antigen-specific n nExposure results in no immunologic memory nSpecific Immunity n nResponse is antigen-dependent n nThere is a lag time between exposure and maximal response n nAntigen-specific n nExposure results in immunologic memory n Systemic manifestation of inflammation à1. Increase of body temperature (fever) à2. Acute phase reaction Systemic effects of acute inflammation nPyrexia n Polymorphs and macrophages produce compounds known as endogenous pyrogens which act on the hypothalamus to set the thermoregulatory mechanisms at a higher temperature. Release of endogenous pyrogen is stimulated by phagocytosis, endotoxins and immune complexes. nConstitutional symptoms n Constitutional symptoms include malaise, anorexia and nausea. Weight loss is common when there is extensive chronic inflammation. nLocal or systemic Iymph node enlargement commonly accompanies inflammation, while splenomegaly is found in certain specific infections (e.g. malaria, infectious mononucleosis). Systemic effects of acute inflammation nHaematological changes ØIncreased erythrocyte sedimentation rate. An increased erythrocyte sedimentation rate is a non-specific finding in many types of inflammation. ØLeukocytosis. Neutrophilia occurs in pyogenic infections and tissue destruction; eosinophilia in allergic disorders and parasitic infection; Iymphocytosis in chronic infection (e .g. tuberculosis), many viral infections and in whooping cough; and monocytosis occurs in infectious mononucleosis and certain bacterial infections (e.g. tuberculosis, typhoid). Anaemia. This may result from blood-loss in the inflammatory exudate (e.g. in ulcerative colitis), haemolysis (due to bacterial toxins), and 'the anaemia of chronic disorders' due to toxic depression of the bone marrow. nAmyloidosis ØLongstanding chronic inflammation (for example, in rheumatoid arthritis, tuberculosis and bronchiectasis), by elevating serum amyloid A protein (SAA), may cause amyloid to be deposited in various tissues resulting in secondary (reactive) amyloidosis Macroscopic appearance of acute inflammation nThe cardinal signs of acute inflammation are modified according to the tissue involved and the type of agent provoking the inflammation. Several descriptive terms are used for the appearances. nSerous inflammation. nCatarrhal inflammation nFibrinous inflammation nHaemorrhagic inflammation nSuppurative (purulent) inflammation nMembranous inflammation nPseudomembranous inflammation nNecrotising (gangrenous) inflammation. ncan be caused by microbial agents such as nviruses, bacteria, fungi and parasites nby non-infectious inflammatory stimuli, as in rheumatoid arthritis and graft-versus-host disease nby tissue necrosis as in cancer nby burns and toxic influences caused by drugs or radiation Acute inflammation Early Stages of Acute Inflammation n nThe acute inflammatory response involves three processes: nchanges in vessel calibre and, consequently, flow nincreased vascular permeability and formation of the fluid exudate nformation of the cellular exudate by emigration of the neutrophil polymorphs into the extravascular space. Early Stages of Acute Inflammation n nThe steps involved in the acute inflammatory response are: nSmall blood vessels adjacent to the area of tissue damage initially become dilated with increased blood flow, then flow along them slows down. nEndothelial cells swell and partially retract so that they no longer form a completely intact internal lining. nThe vessels become leaky, permitting the passage of water, salts, and some small proteins from the plasma into the damaged area (exudation). One of the main proteins to leak out is the small soluble molecule, fibrinogen. nCirculating neutrophil polymorphs initially adhere to the swollen endothelial cells (margination), then actively migrate through the vessel basement membrane (emigration), passing into the area of tissue damage. nLater, small numbers of blood monocytes (macrophages) migrate in a similar way, as do Iymphocytes. n The acute phase reaction nIn the acute phase reaction, several biochemical, metabolic, hormonal and cellular changes take place in order to fight the stimulus and re-establish a normal functional state in the body. nAn increase in the number of granulocytes will increase the phagocytotic capacity, an increase in scavengers will potentiate the capability to neutralise free oxygen radicals, and an increase in metabolic rate will increase the energy available for cellular activities, despite a reduced food intake. nSome of these changes can explain the symptoms of an acute phase reaction, which are typically fever, tiredness, loss of appetite and general sickness, in addition to local symptoms from the inducer of the acute phase. n General and local clinical symptoms of the acute phase reaction General symptoms Local symptoms fever calor increased heart rate rubor hyperventilation dolor tiredness tumor loss of appetite functio laesa Biochemistry and physiology of the acute phase reaction nThe acute phase reaction is the body's first-line inflammatory defence system, functioning without specificity and memory, and in front of, and in parallel with, the adaptive immune system. nCRP is a major acute phase protein acting mainly through Ca2+-dependent binding to, and clearance of, different target molecules in microbes, cell debris and cell nuclear material. nIn an acute phase reaction there may be a more than 1000-fold increase in the serum concentration of CRP. CRP is regarded as an important member of the family of acute phase proteins, having evolved almost unchanged from primitive to advanced species. n Changes compared with normal state Increase Decrease Cellular phagocytotic cells (in circulation and at the site of inflammation) erythrocytes Metabolic acute phase proteins serum Cu protein catabolism gluconeogenesis serum Fe serum Zn albumin synthesis transthyretin transferrin Endocrinological glucagon insulin ACTH GH T4 cortisol aldosterone vasopressin T3 TSH The acute phase proteins ØInduction of the acute phase reaction means changes in the synthesis of many proteins which can be measured in plasma. ØRegulation of protein synthesis takes place at the level of both transcription (DNA, RNA) and translation to protein. ØThe cells have intricate systems for up- and down-regulation of protein synthesis, initiated by a complex system of signals induced in the acute phase reaction. n The acute phase proteins n n Most of the proteins with increased serum concentrations have functions which are easily related nto limiting the negative effects of the acute phase stimulus or nto the repair of inflammatory induced damage. Examples are enzyme inhibitors limiting the negative effect of enzymes released from neutrophils, scavengers of free oxygen radicals, increase in some transport proteins and increased synthesis and activity of the cascade proteins such as coagulation and complement factors. The synthesis may be upregulated even if plasma levels are normal, due to increased consumption of acute phase proteins. n Function Acute phase protein Increase up to Protease inhibitors "a1-antitrypsin a"1-antichymotrypsin 4 fold 6 fold Coagulation proteins fibrinogen prothrombin factor VIII plasminogen 8 fold Complement factors C1s C2b C3, C4, C5 C9 C5b 2 fold Transport proteins haptoglobin haemopexin ferritin 8 fold 2 fold 4 fold Scavenger proteins ceruloplasmin 4 fold Miscellaneous "1-acid glycoprotein (orosomucoid) serum amyloid A protein C-reactive protein 4 fold 1000 fold 1000 C-reactive protein-structure and function nCRP is a cyclic pentamer composed of five non-covalently bound, identical 23.5 kDa subunits. nThe main function of this pentamer is related to the ability to bind biologically significant ligands in vivo. nCRP is found in primitive species like the horse-shoe crab, and evolutionary maintained with few structural changes in higher vertebrates like man. This may indicate that CRP has an important function in the host defence system. n fig04big fig06big Induction and synthesis of CRP in hepatocytes. CRP functions nMost functions of CRP are easily understood in the context of the body's defences against infective agents. nThe bacteria are opsonised by CRP and increased phagocytosis is induced. nCRP activates complement with the split product being chemotactic, increasing the number of phagocytes at the site of infection. Enzyme inhibitors protect surrounding tissue from the damage of enzymes released from the phagocytes. nCRP binds to chromatin from dead cells and to cell debris which are cleared from the circulation by phagocytosis, either directly or by binding to Fc-, C3b- or CRP-specific receptors. Platelet aggregation is inhibited, decreasing the possibility of thrombosis. nCRP binds to low density lipoprotein (LDL) and may clear LDL from the site of atherosclerotic plaques by binding to cell surface receptors on phagocytic cells. fig05big Documented and proposed CRP functions. fig03big Typical changes of CRP, fibrinogen, ESR (erythrocyte sedimentation rate) and albumin during an acute phase reaction Classical pathway of complement activation nnormally requires a suitable Ab bound to antigen (Ag), complement components 1, 4, 2 and 3 and Ca++ and Mg++ cations. nC1 activation Binding of C1qrs (a calcium-dependent complex), present in normal serum, to Ag-Ab complexes results in autocatalysis of C1r. The altered C1r cleaves C1s and this cleaved C1s becomes an enzyme (C4-C2 convertase) capable of cleaving both C4 and C2. nC4 and C2 activation (generation of C3 convertase) Activated C1s enzymatically cleaves C4 into C4a and C4b. C4b binds to the Ag-bearing particle or cell membrane while C4a remains a biologically active peptide at the reaction site. C4b binds C2 which becomes susceptible to C1s and is cleaved into C2a and C2b. C2a remains complexed with C4b whereas C2b is released in the micro environment. C4b2a complex, is known as C3 convertase in which C2a is the enzymatic moiety. nC3 activation (generation of C5 convertase) C3 convertase, in the presence of Mg++, cleaves C3 into C3a and C3b. C3b binds to the membrane to form C4b2a3b complex whereas C3a remains in the micro environment. C4b2a3b complex functions as C5 convertase which cleaves C5 into C5a and C5b. Generation of C5 convertase marks the end of the classical pathway. C1class Classical pathway activation Lectin pathway activation n C4 activation can be achieved without antibody and C1 participation by the lectin pathway. This pathway is initiated by three proteins: a mannan-binding lectin (MBL), also known as mannan-binding protein (MBP) which interacts with two mannan-binding lectin-associated serine proteases (MASP and MADSP2), analogous to C1r and C1s. This interaction generates a complex analogous to C1qrs and leads to antibody -independent activation of the classical pathway. C2MBL Lectin pathway activation Alternative pathway activation n Alternative pathway begins with the activation of C3 and requires Factors B and D and Mg++ cation, all present in normal serum. The alternative pathway provides a means of non-specific resistance against infection without the participation of antibodies and hence provides a first line of defense against a number of infectious agents. h_alternativePathway Alternative pathway of complement activation Lytic pathway nThe lytic (membrane attack) pathway involves the C5-9 components. C5 convertase generated by the classical or alternative pathway cleaves C5 into C5a and C5b. C5b binds C6 and subsequently C7 to yield a hydrophobic C5b67 complex which attaches quickly to the plasma membrane. Subsequently, C8 binds to this complex and causes the insertion of several C9 molecules. bind to this complex and lead to formation of a hole in the membrane resulting in cell lysis. nThe lysis of target cell by C5b6789 complex is nonenzymatic and is believed to be due to a physical change in the plasma membrane. C5b67 can bind indiscriminately to any cell membrane leading to cell lysis. Such an indiscriminate damage to by-standing cells is prevented by protein S (vitronectin) which binds to C5b67 complex and blocks its indiscriminate binding to cells other than the primary target n C7lyt The lytic pathway Biologically active products of complement activation nChemotactic factors C5a and MAC (membrane attack complex C5b67) are both chemotactic. C5a is also a potent activator of neutrophils, basophils and macrophages and causes induction of adhesion molecules on vascular endothelial cells. nOpsonins C3b and C4b in the surface of microorganisms attach to C-receptor (CR1) on phagocytic cells and promote phagocytosis. nOther biologically active products of C activation Degradation products of C3 (iC3b, C3d and C3e) also bind to different cells by distinct receptors and modulate their function. Biologically active products of complement activation nActivation of complement results in the production of several biologically active molecules which contribute to resistance, anaphylaxis and inflammation. nKinin production C2b generated during the classical pathway of C activation is a prokinin which becomes biologically active following enzymatic alteration by plasmin. nAnaphylotoxins C4a, C3a and C5a (in increasing order of activity) are all anaphylotoxins which cause basophil/mast cell degranulation and smooth muscle contraction. Chemotaxis àis directed movement of cells in concentration gradient of soluble extracellular components. àChemotaxis factors, chemotaxins or chemoattractants àPositive chemotaxis = cells move do the places with higher concentrations of chemotactic factors. àNegative chemotaxis = cells move from the places with higher conentrations of chemotactioc factors àChemoinvasion = cells move through basal membrane n Cytokines nThe term cytokine is used as a generic name for a diverse group of soluble proteins and peptides which act as humoral regulators at nano- to picomolar concentrations and which, either under normal or pathological conditions, modulate the functional activities of individual cells and tissues. These proteins also mediate interactions between cells directly and regulate processes taking place in the extracellular environment. Cytokine network n nThis term essentially refers to the extremely complex interactions of cytokines by which they induce or suppress their own synthesis or that of other cytokines or their receptors, and antagonize or synergise with each other in many different and often redundant ways. nThese interactions often resemble Cytokine cascades with one cytokine initially triggering the expression of one or more other cytokines that, in turn, trigger the expression of further factors and create complicated feedback regulatory circuits. nMutually interdependent pleiotropic cytokines usually interact with a variety of cells, tissues and organs and produce various regulatory effects, both local and systemic. cytokinenetwork Cytokines nIn many respects the biological activities of cytokines resemble those of classical hormones produced in specialized glandular tissues. Some cytokines also behave like classical hormones in that they act at a systemic level, affecting, for example, biological phenomena such as inflammation , systemic inflammatory response syndrome , and acute phase reaction , wound healing , and the neuroimmune network . nIn general, cytokines act on a wider spectrum of target cells than hormones. Perhaps the major feature distinguishing cytokines from mediators regarded generally as hormones is the fact that, unlike hormones, cytokines are not produced by specialized cells which are organized in specialized glands, i. e. there is not a single organ source for these mediators. nThe fact that cytokines are secreted proteins also means that the sites of their expression does not necessarily predict the sites at which they exert their biological function. Subpopulations of helper T cells: Th1 and Th2 n nWhen a naive CD4+ T cell (Th0 cell) responds to antigen in secondary lymphoid tissues, it is capable of differentiating into an inflammatory Th1 cell or a helper Th2 cell, which release distinctive patterns of cytokines. nFunctionally these subpopulations, when activated, affect different cells. Th1/Th2 cytokines àTh-1 (=cytokines type 1) and Th-2 (cytokines type 2) are secreted by different subpopulations of T-lymphocytes, monocytes, natural killers, B-lymphocytes, eosinophiles, basophiles, mastocytes. àTh-1-helps cellular immunity response [IL-2, IFNg (IL-18), TNFb] àTh-2-hepls B-cell development and antibody secretion (IgE) (IL-4, IL-5, IL-6, IL-10, IL-13) central Th cells are at the center of cell-mediated immunity. The antigen-presenting cells present antigen to the T helper (Th) cell. The Th cell recognises specific epitopes which are selected as target epitopes. Appropriate effector mechanisms are now determined. For example, Th cells help the B cells to make antibody and also activate other cells. The activation signals produced by Th cells are cytokines (lymphokines) but similar cytokines made by macrophages and other cells also participate in this process select-3 Selection of effector mechanisms by Th1 and Th2 cells. In addition to determining various effector pathways by virtue of their lymphokine production, Th1 cells switch off Th2 cells and vice versa. MediaObjects/281_2007_67_Fig1_HTML.gif Th1/Th2 paradigm develops into Th1/Th2/Th3/Tr1 paradigm and more. T cells are classified into CD4+ T cells and CD8+ T cells by their surface markers, and these cells are further classified into Th1 cells, Th2 cells, Tc1 cells, and Tc2 cells by their cytokine profile. The Th1 cells and Tc1 cells are involved in cellular immunity, and the Th2 and Tc2 cells are involved in humoral immunity. Recently, other cell types are reported Th3 cells, which produced TGF-β, Tr1 cells, which produce IL-10, and CD4+CD25+ regulatory T cells regulate overstimulation of type 1 immunity or type 2 immunity. NK cells also classified into NK1 and NK2 cells by their cytokine profile. Other cell types, NK3, NKr1, and regulatory NK cells have been reported recently. MediaObjects/281_2007_67_Fig4_HTML.gif Th1/Th2/Th3/Tr1 and NK1/NK2/NK3/NKr1 balance in nonpregnancy subjects, pregnancy subjects, and spontaneous abortion cases. In the immunostimulation system, Th1/Th2 and NK1/NK2 are balanced, and these immunostimulation systems are regulated by immunoregulation system such as Tr1, NKr1, Th3, NK3, and CD4+CD25+ Treg cells. These balances are different between peripheral blood lymphocytes and decidual lymphocytes (Saito et al., 2007) Regeneration. Wound healing Wound healing nis a natural restorative response to tissue injury. nHealing is the interaction of a complex cascade of cellular events that generates resurfacing, reconstitution, and restoration of the tensile strength of injured skin. nUnder the most ideal circumstances, healing is a systematic process, traditionally explained in terms of 3 classic phases: inflammation, proliferation, and maturation. Wound healing nThe inflammatory phase: a clot forms and cells of inflammation debride injured tissue during. nThe proliferative phase: epithelialization, fibroplasia, and angiogenesis occur; additionally, granulation tissue forms and the wound begins to contract. nThe maturation phase: Collagen forms tight cross-links to other collagen and with protein molecules, increasing the tensile strength of the scar. wound1 Inflammatory Phase nThe body responds quickly to any disruption of the skin’s surface. nWithin seconds of the injury, blood vessels constrict to control bleeding at the site. nPlatelets coalesce within minutes to stop the bleeding and begin clot formation. Inflammatory Phase nEndothelial cells retract to expose the subendothelial collagen surfaces; nplatelets attach to these surfaces. nAdherence to exposed collagen surfaces and to other platelets occurs through adhesive glycoproteins: fibrinogen, fibronectin, thrombospondin, and von Willebrand factor. cb09t1977001 Blood clot formation Inflammatory Phase nThe aggregation of platelets results in the formation of the primary platelet plug. Aggregation and attachment to exposed collagen surfaces activates the platelets. nActivation enables platelets to degranulate and release chemotactic and growth factors, such as platelet-derived growth factor (PDGF), proteases, and vasoactive agents (eg, serotonin, histamine). Inflammatory Phase nThe coagulation cascade occurs by 2 different pathways. nThe intrinsic pathway begins with the activation of factor XII (Hageman factor), when blood is exposed to extravascular surfaces. nThe extrinsic coagulation pathway occurs through the activation of tissue factor found in extravascular cells in the presence of factors VII and VIIa. Inflammatory Phase nThe result of platelet aggregation and the coagulation cascade is clot formation. nClot formation is limited in duration and to the site of injury. nClot formation dissipates as its stimuli dissipate. Plasminogen is converted to plasmin, a potent enzyme aiding in cell lysis. nClot formation is limited to the site of injury because uninjured nearby endothelial cells produce prostacyclin, an inhibitor of platelet aggregation. In the uninjured nearby areas, antithrombin III binds thrombin, and protein C binds factors of the coagulation cascade, namely, factors V and VII. Inflammatory phase nBoth pathways proceed to the activation of thrombin, which converts fibrinogen to fibrin. nThe fibrin product is essential to wound healing and is the primary component of the wound matrix into which inflammatory cells, platelets, and plasma proteins migrate. nRemoval of the fibrin matrix impedes wound healing. Inflammatory Phase nIn addition to activation of fibrin, thrombin facilitates migration of inflammatory cells to the site of injury by increasing vascular permeability. By this mechanism, factors and cells necessary to healing flow from the intravascular space and into the extravascular space. Inflammatory Phase nPlatelets also release factors that attract other important cells to the injury. nNeutrophils enter the wound to fight infection and to attract macrophages. nMacrophages break down necrotic debris and activate the fibroblast response. nThe inflammatory phase lasts about 24 hours and leads to the proliferation phase of the healing process. Proliferation Phase n nOn the surface of the wound, epidermal cells burst into mitotic activity within 24 to 72 hours. These cells begin their migration across the surface of the wound. nFibroblasts proliferate in the deeper parts of the wound. These fibroblasts begin to synthesize small amounts of collagen which acts as a scaffold for migration and further fibroblast proliferation. n Proliferation Phase n nGranulation tissue, which consists of capillary loops supported in this developing collagen matrix, also appears in the deeper layers of the wound. nThe proliferation phase lasts from 24 to 72 hours and leads to the maturation phase of wound healing. Proliferation Phase n nFour to five days after the injury occurs, fibroblasts begin producing large amounts of collagen and proteoglycans. nProteoglycans appear to enhance the formation of collagen fibers, but their exact role is not completely understood. nCollagen fibers are laid down randomly and are cross-linked into large, closely packed bundles. Proliferation Phase n nWithin two to three weeks, the wound can resist normal stresses, but wound strength continues to build for several months. nThe proliferation phase lasts from 15 to 20 days and then wound healing enters the maturation phase. Picture%2011 Picture%2008 Picture%2013 Maturation Phase nDuring the maturation phase, fibroblasts leave the wound and collagen is remodelled into a more organized matrix. nTensile strength increases for up to one year following the injury. While healed wounds never regain the full strength of uninjured skin, they can regain up to 70 to 80% of its original strength. Picture%2015 Picture%2004 Chronic Wounds nFailure or delay of healing components nUnresponsiveness to normal growth regulatory signals nAssociated with repeated trauma, poor prefusion/oxygenation and/or excessive inflammation nSystemic disease nGenetic factors Factors affecting wound healing nLocal nRegional nSystemic Local factors affecting wound healing nMechanical injury nInfection edema nIschemia/hypoxia/necrosis nTopical factors nIonizing radiation nForeign bodies Regional factors affecting wound healing nArterial insufficiency nVenous insufficiency nNeuropathy Systemic factors affecting wound healing nHypoperfusion nInflammation nNutrition nMetabolic diseases nImmunodefficiency/ immunosupression nConnective tissue disorders nSmoking n Picture%2026 Picture%2027 Thank you for your attention. newpiano